Prescription drug · ANDA
Mirtazapine NDC 67046-1590
Mirtazapine 15 mg/1 · Tablet, Film coated · Oral · Coupler LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67046-1590-3 | 67046159003 | 30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1590-3)Marketed from Sep 16, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mirtazapine
- Generic name (nonproprietary)
- mirtazapine
- Active ingredients
- Mirtazapine — 15 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Coupler LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077666
- Marketing start
- Listing expires
- Identifiers
- Product ID 67046-1590_3eed81ad-e8ac-db55-e063-6394a90a054cSPL ID 3eed81ad-e8ac-db55-e063-6394a90a054cSPL set ID 3eed8213-a240-fc4b-e063-6294a90a3b05RxCUI 311725UNII A051Q2099Q
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467046159003followed by a unit qualifier and the quantityPackage 67046-1590-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] . Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077666
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Mirtazapine | Mirtazapine 15 mg/1 | Tablet, Film coatedOral | Proficient Rx LP | 63187-206 |
| Mirtazapine | Mirtazapine 30 mg/1 | Tablet, Film coatedOral | AvKARE | 42291-952 |
| Mirtazapine | Mirtazapine 15 mg/1 | Tablet, Film coatedOral | Direct_Rx | 61919-153 |
| Mirtazapine | Mirtazapine 30 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-378 |
| Mirtazapine | Mirtazapine 15 mg/1 | Tablet, Film coatedOral | McKesson Corporation dba SKY Packaging | 63739-098 |
| Mirtazapine | Mirtazapine 30 mg/1 | Tablet, Film coatedOral | McKesson Corporation dba SKY Packaging | 63739-099 |
| Mirtazapine | Mirtazapine 30 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-1058 |
| Mirtazapine | Mirtazapine 45 mg/1 | Tablet, Film coatedOral | Proficient Rx LP | 63187-471 |
| Mirtazapine | Mirtazapine 15 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-6519 |
| Mirtazapine | Mirtazapine 30 mg/1 | Tablet, Film coatedOral | Apotex Corp. | 60505-0248 |
| Mirtazapine | Mirtazapine 15 mg/1 | Tablet, Film coatedOral | Apotex Corp. | 60505-0247 |
| Mirtazapine | Mirtazapine 45 mg/1 | Tablet, Film coatedOral | Apotex Corp. | 60505-0249 |
| Mirtazapine | Mirtazapine 30 mg/1 | Tablet, Film coatedOral | Proficient Rx LP | 63187-554 |
| Mirtazapine | Mirtazapine 15 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-717 |
| Mirtazapine | Mirtazapine 15 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-7297 |